Literature DB >> 21295284

Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions.

Luke G Gutwein1, Darwin N Ang, Huazhi Liu, Julia K Marshall, Steven N Hochwald, Edward M Copeland, Stephen R Grobmyer.   

Abstract

BACKGROUND: Percutaneous needle biopsy, also known as minimally invasive breast biopsy (MIBB), has become the gold standard for the initial assessment of suspicious breast lesions. The purpose of this study is to determine modern rates of MIBB and open breast biopsy.
METHODS: The Florida Agency for Health Care Administration outpatient surgery and procedure database was queried for patients undergoing open surgical biopsy and MIBB between 2003 and 2008.
RESULTS: Although there was an increase in the use of MIBB, the overall rate of open surgical biopsy remained high (∼30%). A reduction in the open biopsy rate from 30% to 10% could be associated with a charge reduction of >$37.2 million per year.
CONCLUSIONS: The current rate of open surgical breast biopsy remains high. Interventions and quality initiatives are warranted, which could lead to a reduction in unnecessary operations for women, improved patient care, and a reduction in breast health care costs.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21295284     DOI: 10.1016/j.amjsurg.2010.09.005

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  20 in total

1.  Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.

Authors:  Katherine D Crew
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

2.  Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.

Authors:  Daniel W Visscher; Marlene H Frost; Lynn C Hartmann; Ryan D Frank; Robert A Vierkant; Ann E McCullough; Stacey J Winham; Celine M Vachon; Karthik Ghosh; Kathleen R Brandt; Ann M Farrell; Yaman Tarabishy; Tina J Hieken; Tufia C Haddad; Ruth A Kraft; Derek C Radisky; Amy C Degnim
Journal:  Cancer       Date:  2015-10-29       Impact factor: 6.860

3.  Model for individualized prediction of breast cancer risk after a benign breast biopsy.

Authors:  V Shane Pankratz; Amy C Degnim; Ryan D Frank; Marlene H Frost; Daniel W Visscher; Robert A Vierkant; Tina J Hieken; Karthik Ghosh; Yaman Tarabishy; Celine M Vachon; Derek C Radisky; Lynn C Hartmann
Journal:  J Clin Oncol       Date:  2015-01-26       Impact factor: 44.544

4.  Surgeon and Facility Variation in the Use of Minimally Invasive Breast Biopsy in Texas.

Authors:  Nina P Tamirisa; Kristin M Sheffield; Abhishek D Parmar; Christopher J Zimmermann; Deepak Adhikari; Gabriela M Vargas; Yong-Fang Kuo; James S Goodwin; Taylor S Riall
Journal:  Ann Surg       Date:  2015-07       Impact factor: 12.969

5.  Atypical hyperplasia of the breast--risk assessment and management options.

Authors:  Lynn C Hartmann; Amy C Degnim; Richard J Santen; William D Dupont; Karthik Ghosh
Journal:  N Engl J Med       Date:  2015-01-01       Impact factor: 91.245

6.  Fine-needle aspiration cytology in the evaluation of patients with radiographically occult, palpable breast abnormalities.

Authors:  Nicolas Ajkay; Erica V Bloomquist; Robert C G Martin; Thomas G Frazier; Andrea V Barrio
Journal:  Surgery       Date:  2015-08-14       Impact factor: 3.982

7.  Time trends and geographic variation in use of minimally invasive breast biopsy.

Authors:  Christopher J Zimmermann; Kristin M Sheffield; Casey B Duncan; Yimei Han; Catherine D Cooksley; Courtney M Townsend; Taylor S Riall
Journal:  J Am Coll Surg       Date:  2013-02-01       Impact factor: 6.113

8.  Surgeon influence on use of needle biopsy in patients with breast cancer: a national medicare study.

Authors:  Jan M Eberth; Ying Xu; Grace L Smith; Yu Shen; Jing Jiang; Thomas A Buchholz; Kelly K Hunt; Dalliah M Black; Sharon H Giordano; Gary J Whitman; Wei Yang; Chan Shen; Linda Elting; Benjamin D Smith
Journal:  J Clin Oncol       Date:  2014-06-09       Impact factor: 44.544

9.  Utilization of Percutaneous Needle Biopsy for Breast Diagnosis in a Comprehensive Breast Center: Implications for Development of Quality Indicators.

Authors:  Claire M B Holloway; Lolwah Al-Riyees; Refik Saskin
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

10.  The Impact of Acquisition Dose on Quantitative Breast Density Estimation with Digital Mammography: Results from ACRIN PA 4006.

Authors:  Lin Chen; Shonket Ray; Brad M Keller; Said Pertuz; Elizabeth S McDonald; Emily F Conant; Despina Kontos
Journal:  Radiology       Date:  2016-03-22       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.